Diagnostic criteria for erosive lichen planus affecting the vulva: an international electronic-Delphi consensus exercise by Simpson, R. C. et al.
CLINICAL AND LABORATORY INVESTIGATIONS
BJD
British Journal of Dermatology
Diagnostic criteria for erosive lichen planus affecting the
vulva: an international electronic-Delphi consensus
exercise
R.C. Simpson,1 K.S. Thomas,1 P. Leighton2 and R. Murphy3
1Centre of Evidence Based Dermatology, and 2Division of Primary Care, University of Nottingham, King’s Meadow Campus Lenton Lane, Nottingham NG7 2NR, U.K.







R.C.S. is a dermatology doctoral research fellow
supported through the National Institute for Health
Research Doctoral Research Fellowship scheme
(DRF-2012-05-166). This report is independent
research arising from a Doctoral Research Fellow-
ship supported by the National Institute for Health
Research. The views expressed in this publication
are those of the author(s) and not necessarily those
of the NHS, the National Institute for Health





Background There is no defined set of criteria for diagnosing erosive lichen planus
affecting the vulva (ELPV) and there is geographical variation in management.
Objectives To reach consensus on clinicopathological diagnostic criteria for ELPV.
Methods This was a three-stage international electronic-Delphi exercise with a subse-
quent formal feedback process. In the first two rounds participants were asked to rate
the importance of a list of clinicopathological criteria. Responses from round 1 were
summarized and presented in round 2, along with additional criteria suggested by
participants. In round 3, participants were asked to rate the items that had reached
consensus as ‘essential’ or ‘supportive’ features in diagnosing ELPV. Consensus was
defined as being reached if 75% of participants agreed on the importance of an item.
Results A total of 73 experts representing dermatology, gynaecology, histopathol-
ogy and genitourinary medicine participated; 69 (95%) completed all three
rounds. Consensus was achieved for the following ‘supportive’ diagnostic criteria:
(i) well-demarcated erosions/erythematous areas at the vaginal introitus; (ii)
presence of a hyperkeratotic border to lesions and/or Wickham striae in sur-
rounding skin; (iii) symptoms of pain/burning; (iv) scarring/loss of normal
architecture; (v) presence of vaginal inflammation; (vi) involvement of other
mucosal surfaces; (vii) presence of a well-defined inflammatory band involving
the dermoepidermo junction; (viii) presence of an inflammatory band consisting
predominantly of lymphocytes; and (ix) signs of basal layer degeneration. It was
suggested that at least three supportive features should be present to make a diag-
nosis of ELPV, although this number is subject to further discussion.
Conclusions This study has identified a diagnostic dataset for ELPV that can be
adopted into clinical practice and clinical trials.
What’s already known about this topic?
• Erosive lichen planus affecting the vulva (ELPV) is an uncommon inflammatory
dermatosis that is often resistant to first-line therapy.
• There are no published criteria for the diagnosis of ELPV.
What does this study add?
• Using the electronic-Delphi technique we have collated a set of nine diagnostic cri-
teria internationally agreed by physicians with expertise in the diagnosis and man-
agement of vulval disease including ELPV.
• It is thought that at least three out of the nine supportive criteria should be present
in order to diagnose ELPV, but this number requires further validation.
• This diagnostic dataset will guide the clinical diagnosis of ELPV and will standard-
ize the inclusion of patients into clinical trials.
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Erosive lichen planus (ELP) is a chronic, T-cell-mediated
inflammatory condition affecting the squamous epithelium. It
involves mucocutaneous sites, particularly the orogenital
mucosa. Most clinicians managing vulvar diseases would
diagnose ELP affecting the vulva (ELPV) following careful
clinicopathological correlation.1 However, unlike oral lichen
planus, which has a defined set of diagnostic criteria as set
out by the World Health Organization in 19782 and subse-
quently modified in 2003, the same does not exist for vulval
disease.
ELPV may mimic other conditions such as lichen sclerosus
(with which it may overlap clinically and histopathologically),3–5
autoimmune bullous disorders and intraepithelial carcinoma.4
The diagnosis can therefore be challenging.
Early recognition of vulvovaginal lichen planus is important
to minimize unnecessary medical or surgical procedures and
to instigate prompt treatment and alleviation of symptoms.6,7
However, ELPV may present to a range of specialties such as
general dermatology, gynaecology and genitourinary medi-
cine, where variation in diagnosis and management exists.8
An agreed diagnostic dataset would be valuable to standard-
ize practice, to assist nonexperts in making a correct diagnosis
and to regulate inclusion into clinical trials. The purpose of
this international, multiperspective, electronic-Delphi (e-Del-
phi) consensus exercise was to reach agreement on a diagnos-




This was a three-stage, international e-Delphi exercise that was
conducted between October 2012 and December 2012. The
Delphi process is widely used in clinical and health services
research;9 it is an iterative technique based on the scoring of a
series of structured statements that are revised and repeated
until consensus has been reached among a panel of expert
participants.10 It is a method frequently used for establishing
diagnostic criteria.11,12 We conducted this study as an elec-
tronic process and the exercise was moderated by a single cen-
tral coordinator (R.C.S.).
Participants
A letter of invitation was emailed to all members of the Inter-
national Society for the Study of Vulvovaginal Disease (ISSVD)
and members of the British Society for the Study of Vulval
Disease (BSSVD). These are multidisciplinary societies compris-
ing experts from different stakeholder groups who manage
patients with vulvovaginal disease. Members of these societies
were identified as potential participants of this e-Delphi study
as they are professionals with a specialist interest in the
relevant field, they will directly utilize the outcomes of the
e-Delphi study in their daily practice and they have the skill
set to make an insightful, well-informed contribution to the
exercise.
No inconvenience allowance was offered and response to
the initial invitation was taken as implied consent to partici-
pate in the study. Ethical approval was not required as all par-
ticipants were healthcare professionals who participated as part
of their professional role.
Study procedures
To provide an evidence base for the consensus exercise, a
review of the literature was undertaken to summarize diagnos-
tic criteria that have been used in previous studies of ELPV. In
addition, items perceived important by 25 clinicians were elic-
ited through a set of structured interviews.13 The results from
these two exercises were collated to form a structured ques-
tionnaire that contained a list of 12 potential diagnostic crite-
ria required for the diagnosis of ELPV. The study protocol was
finalized in September 2012.
The exercise was conducted anonymously, except for the
coordinator, who was required to know participants’ details
for administrative purposes. Participants were asked specifically
for their consent to be acknowledged in future presentation or
publication.
Questionnaires were completed using the online ‘SurveyMon-
key’ tool.14 A 2-week period for each round was given in which
participants could submit their responses.15 Reminders for each
round were sent at 7, 10 and 14 days to nonresponders.
In the first round of the e-Delphi exercise, participants were
asked to rate the importance of the selected 12 diagnostic cri-
teria on a five-point Likert scale (‘very important’, ‘important’,
‘less important’, ‘not important’ and ‘not sure’). When dis-
cussing histological criteria, it was specified that biopsy sam-
ples should be taken from the edge of an erosion where
representative histology would most likely be present. Con-
tributors were asked to list any additional diagnostic features
not in the original list that they considered relevant. The sur-
vey instrument was amended following round 1. Diagnostic
items for which consensus was reached as ‘not important’
were removed and additional diagnostic items were incorpo-
rated into the questionnaire.
In the second round summary scores for round 1 were pre-
sented and respondents could submit new answers or leave
their original responses unchanged. The same process of
analysis and amendment of the survey tool occurred to create
the round 3 questionnaire.
In the third round participants were asked to rate criteria
that had reached consensus as important as ‘essential’, ‘sup-
portive’ or ‘neither’. ‘Essential’ was defined as a diagnostic
feature that must be present to make a diagnosis of ELPV.
‘Supportive’ was classed as a feature that does not have to be
present, but adds weight to other diagnostic features that are
present. Participants were also asked how many essential and/
or supportive diagnostic criteria should be present to make a
diagnosis of ELPV.
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It was made clear throughout all rounds if questions had
been amended, added or excluded following analysis of previ-
ous rounds. Participants were given the opportunity to com-
ment on any of these amendments. After completion and
analysis of all three rounds, the findings were circulated for
formal feedback and comments from the participants.
Definition of consensus
Consensus was defined as being reached if 75% of participants
agreed on the importance of an item, i.e. rated it ‘very impor-
tant’ or ‘important’ on the Likert scale, or agreed whether an
item should be ‘essential’ or ‘supportive’. As a soft measure of
consensus to avoid premature exclusion of diagnostic items,
we also carried through items that less than 25% of partici-
pants had rated ‘not important’ or ‘unsure’. Diagnostic criteria
that did not achieve consensus/soft consensus were excluded
from subsequent rounds of the exercise.
Results
The letter of invitation was circulated to 283 members of the
ISSVD and 175 members of the BSSVD. Some physicians were
members of both societies but for confidentiality reasons these
data are unknown. A total of 73 individuals participated in the
first round. Of these, 71 (97%) completed the second round
and 69 (95%) completed the final round. The formal feedback
survey was completed by 54 participants.
Participants represented four distinct stakeholder groups and
were from 14 different countries. The majority had over
10 years’ experience in managing patients with vulval skin
disease and 88% of respondents were either professors or con-
sultants in their field. Characteristics of the participants are
shown in Table 1.
Following the first round, two clinical and three histopatho-
logical items were added to the round 2 questionnaire. Addi-
tionally, the wording of four questions was amended for
clarity.
Six potential diagnostic criteria were removed following
rounds 1 and 2 as participants’ answers indicated these were
not important to diagnose ELPV (Table 2).
Ten diagnostic features (six clinical and four histopathologi-
cal) reached consensus, or soft consensus, and were carried
through to the third round for final approval (Table 3).
In the third and final round, participants were asked to rank
items as ‘essential’ or ‘supportive’ diagnostic criteria, or nei-
ther (Table 4). No diagnostic indicator reached consensus as
being ‘essential’. The ‘absence of dermal hyalinization’ on his-
topathological examination was not favoured as being in the
final dataset. The remaining nine diagnostic items were recom-
mended as being supportive diagnostic criteria (Table 4); the
resulting dataset therefore consisted of nine criteria that repre-
sent clinicopathological features of ELP. Of the 54 participants
who provided feedback 93% were in agreement with this.
When asked in round 3 how many supportive features
should be present to diagnose ELPV, consensus was reached
for at least three out of nine needing to be present. However,
following participant feedback, opinion was divided between
three or four supportive features being required.
During the exercise, participants were asked about the
importance of performing diagnostic biopsy. There was dis-
parity in opinion, with 36/69 (52%) responding that a diag-
nosis of ELPV does not always have to satisfy clinical and
histopathological criteria. However, 63/69 (91%) acknowl-
edged that a biopsy should be performed if there was
diagnostic uncertainty or concern of neoplastic change.
The differential diagnoses identified as most likely to cause
diagnostic difficulty were lichen sclerosus and mucosal
autoimmune bullous disorders.
Discussion
This exercise enabled the collation of a set of nine diagnostic
criteria defined by experts as supportive of the diagnosis of
ELPV (Table 5); no essential features were identified. It was
agreed that three or more of these supportive features are
required to diagnose ELPV and these can be a combination of
both histological and clinical features. However, feedback
from participants suggested that more focused work is
required to determine whether this is the optimum number of
features and whether the individual items should be weighted.
The e-Delphi method was used to answer a research question
that required specialist input from the clinical community as
these data were not available in the existing literature. The Del-
phi technique is characterized by four core features: the involve-
ment of an expert panel, multiple iterations, feedback between
rounds and anonymity.16 The latter is particularly important as
in face-to-face group-based processes the presence of dominant
individuals can have a large influence on the results.15 Each of
these core features was embodied by this study.
Due to the study conduct being via web-based communica-
tion, geographical constraints were overcome and anonymity
of participants was maintained. There was a high degree of
experience and skill within the recruited group. All partici-
pants were members of specialist societies with a specific
interest in vulvovaginal disease. The demographics of the
group indicate that respondents had the necessary skills and
experience to contribute to the derived diagnostic dataset.
We ran three rounds of the Delphi exercise, which enabled
the study to be completed in a timely manner without partici-
pants developing survey ‘fatigue’. Feedback indicated that
three rounds were sufficient to formulate a list of clinicopath-
ological features that are suggestive of ELPV, but further work
is needed to determine the exact number of these criteria
required.
Important considerations when interpreting the results of
this exercise are that two of the stakeholder groups,
dermatopathology and genitourinary medicine, were under-
represented. Reliability of responses from individual groups
diminishes with numbers of fewer than 12 and are consid-
ered to be unreliable with six or fewer.10 While dermatol-
ogy and gynaecology expertise was adequately represented
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by respondents (Table 1), histological opinion was not,
as only seven dermatopathologists took part. Individual
histopathologists did comment that epidermal changes such
as sawtoothed acanthosis and hypergranulosis, and dermal
changes of lack of hyalinization, were important. These
comments were not sufficient to alter the results; however,
findings may be different with larger numbers. We do not
know if the views of the seven dermatopathologists were
representative of the profession as a whole, but it was
beyond the scope of this exercise to investigate further.







Total participants in each round 73 71 69
Stakeholder group
Dermatology 30 (41) 30 (42) 30 (43)
Gynaecology ( obstetrics) 30 (41) 28 (39) 26 (38)
Histopathology/dermatopathology 7 (10) 7 (10) 7 (10)
Genitourinary medicine/venerology 6 (8) 6 (8) 6 (9)
Grade
Professor/associate professor 19 (26) 18 (25) 17 (25)
Consultant 45 (62) 45 (63) 45 (65)
Associate specialist 6 (8) 5 (7) 4 (6)
Resident/specialist registrar 2 (3) 2 (3) 2 (3)
Specialist nurse 1 (1) 1 (1) 1 (1)
Country
Argentina 2 2 2
Australia 7 7 7
Canada 3 3 3
Denmark 1 1 1
France 2 2 1
Germany 1 1 1
Israel 1 1 1
Italy 2 2 2
Netherlands 3 3 3
New Zealand 1 1 1
Portugal 1 1 1
U.K. 34 33 33
Uruguay 1 1 1
U.S.A. 14 13 12
Duration of experience
< 5 years 11 (15) 8 (11) 7 (10)
6–10 years 12 (16) 13 (18) 12 (17)
11–15 years 15 (21) 15 (21) 14 (20)
16–20 years 18 (25) 18 (25) 22 (32)
> 20 years 17 (23) 17 (24) 14 (20)
Table 2 Diagnostic criteria excluded after first and second Delphi rounds (> 25% participants considered these ‘not important’ or ‘not sure’)
Diagnostic item
Responses, n (%)
Very important Important Less important Not important Not sure
Excluded after round 1
Presence of symmetrical lesions 2 (3) 9 (12) 30 (41) 30 (41) 2 (3)
Presence of vaginal discharge 1 (1) 10 (14) 30 (41) 30 (41) 2 (3)
Presence of pain on Q-tip pressure 2 (3) 8 (11) 21 (29) 38 (52) 4 (5)
Excluded after round 2
Findings on wet mount preparation 2 (3) 5 (7) 27 (38) 28 (39) 9 (13)
Presence of epidermal changes on
histopathological examination
5 (7) 20 (28) 25 (35) 8 (11) 13 (18)
Direct immunofluorescence 3 (4) 12 (17) 29 (41) 20 (28) 7 (10)
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It was important to do this exercise for two reasons: firstly to
improve the diagnosis of an uncommon condition and improve
patient care, and secondly to define stringent diagnostic criteria
so that robust clinical trials can be carried out to improve cur-
rent patient management.8 This is particularly crucial as patients
with ELPV may present to various specialty groups.
Participants agreed that ELPV can be diagnosed clinically
and a biopsy does not always need to be taken. However,
Table 3 Round 2 results. Items that reached consensus as important (i.e. where > 75% participants rated ‘very important’ or ‘important’; in normal
text) were carried through into the final round. Items that did not meet this cut-off, but where < 25% participants rated ‘not important’ or ‘not
sure’, were also carried through as a measure of ‘soft consensus’ (marked in italics). Items that were dropped following round 2 are in bold
Diagnostic item
Responses, n (%)
Very important Important Less important Not important Not sure
Clinical
Presence of well-demarcated erosions or
glazed erythema at the vaginal introitus
41 (58) 26 (37) 0 (0) 1 (1) 3 (4)
Scarring/loss of normal architecture 13 (18) 46 (65) 10 (14) 0 (0) 2 (3)
Presence of a hyperkeratotic white border
to erythematous areas/
erosions  Wickham striae in
surrounding skin
9 (13) 37 (52) 21 (30) 2 (3) 2 (3)
Presence of vaginal
inflammation  vaginal scarring
7 (10) 20 (28) 34 (48) 8 (11) 2 (283)
Involvement of other mucosal sites, e.g.
mouth, oesophagus
13 (18) 31 (44) 21 (30) 4 (6) 2 (3)
Symptoms of pain/burning 16 (2253) 32 (45) 18 (25) 3 (4) 2 (3)
Findings on wet mount preparation 2 (3) 5 (7) 27 (38) 28 (39) 9 (13)
Histopathological
Presence of a well-defined inflammatory
band in the superficial connective tissue
that involves the dermoepidermal
junction
27 (38) 40 (56) 3 (4) 0 (0) 1 (1)
Presence of an inflammatory band that
consists predominantly of lymphocytes
6 (8) 60 (85) 3 (4) 0 (0) 2 (3)
Signs of basal cell layer degeneration, e.g.
Civatte bodies, abnormal keratinocytes or
basal apoptosis
13 (18) 47 (66) 7 (10) 0 (0) 4 (6)
Absence of dermal hyalinization 8 (11) 17 (24) 29 (41) 3 (4) 14 (20)
Epidermal changes, e.g. wedge-shaped
hypergranulosis, saw-toothed acanthosis
5 (7) 20 (28) 25 (35) 8 (11) 13 (18)
Findings on direct immunofluorescence 3 (4) 12 (17) 29 (41) 20 (28) 7 (10)
Table 4 Round 3 results; essential and supportive diagnostic criteria and final diagnostic dataset. The item that did not reach consensus and was




Presence of well-demarcated erosions or glazed erythema at the vaginal introitus 44 (64) 24 (35) 1 (1)
Presence of a hyperkeratotic white border to erythematous areas/erosions  Wickham’s
striae in surrounding skin
8 (12) 57 (83) 4 (6)
Symptoms of pain/burning 13 (19) 47 (68) 9 (13)
Scarring/loss of normal architecture 10 (14) 55 (80) 4 (6)
Presence of vaginal inflammation 7 (10) 48 (70) 14 (20)
Involvement of other mucosal sites 1 (1) 66 (96) 2 (3)
Presence of a well-defined inflammatory band in the superficial connective tissue that
involves the dermo-epidermo junction
37 (54) 32 (46) 0 (0)
Presence of an inflammatory band that consists predominantly of lymphocytes 30 (43) 37 (54) 2 (3)
Signs of basal cell layer degeneration, e.g. Civatte bodies, abnormal keratinocytes or basal
apoptosis
24 (35) 43 (62) 2 (3)
Absence of dermal hyalinization 11 (16) 38 (55) 20 (29)
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biopsy should be performed in cases of diagnostic doubt or if
there is suspicion of malignancy.
The site of biopsy is important as histological features
described in the diagnostic dataset are more likely to be pres-
ent at the edge of an erosion than centrally. Classical lichenoid
features are most likely to be found when taken from the
white margin of erosions.6 Assessment of vulval biopsies
should be by a dermato- or gynaepathologist as changes of
lichen planus are often subtle and there is a possibility of an
incorrect diagnosis being made by pathologists who are inex-
perienced in this field.17
The interest and high fidelity demonstrated in all three
rounds shows that physicians internationally are motivated to
advance practice in this area of vulvovaginal disease; 73
experts participated in the first round and only four dropped
out during the 9-week study period.
It should be realized that this is just one utility of the Delphi
process and the methodology can be translated to other areas of
healthcare where information in the scientific literature is lack-
ing and therefore needs to be generated using expert opinion,
for example in establishing core outcome sets.18
In conclusion, this consensus exercise represents the views
of a group of experts and provides a list of supportive features
that are considered central to diagnosing ELPV. The next steps
are to validate the diagnostic criteria in the clinical setting by
applying them to patients managed during normal practice.
We envisage that the diagnostic criteria will guide physicians
in their daily practice and that future clinical trials in this field
will utilize common diagnostic criteria to ensure inclusion of
comparable participants.
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